Biprogy Inc. logo

Biprogy Inc. (8056)

Market Closed
10 Aug, 06:00
JPX JPX
¥
4,359. 00
+54
+1.2544%
¥
- Market Cap
- P/E Ratio
- Div Yield
640,200 Volume
- Eps
¥ 4,305
Previous Close
Add Transaction
Day Range
4,288 4,412
Year Range
4,036 6,594
Want to track 8056 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

8056 closed yesterday higher at ¥4,359, an increase of 1.2544% from Friday's close, completing a monthly increase of 2.4924% or ¥106. Over the past 12 months, 8056 stock lost -19.7681%.
8056 pays dividends to its shareholders, with the most recent payment made on Sep 29, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of ¥70.
The last earnings report, released on Apr 30, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on JPX (JPY).

8056 Chart

Biprogy Inc. (8056) FAQ

What is the stock price today?

The current price is ¥4,359.00.

On which exchange is it traded?

Biprogy Inc. is listed on JPX.

What is its stock symbol?

The ticker symbol is 8056.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Biprogy Inc. ever had a stock split?

No, there has never been a stock split.

Biprogy Inc. Profile

Insurance Industry
Financials Sector
Mr. Wade Menpes-Smith CEO
JPX Exchange
JP3754200008 ISIN
Germany Country
3 Employees
29 Sep 2026 Last Dividend
- Last Split
- IPO Date

Overview

Aladdin Healthcare Technologies SE is a pioneering company focusing on the innovative use of blockchain technology to enhance healthcare. By leveraging blockchain, the company ensures secure and efficient storage and management of health-related information. With its subsidiary, Aladdin Healthcare Technologies Ltd, it is at the forefront of harnessing Artificial Intelligence (AI) for the discovery of new drugs and the improvement of healthcare outcomes. The company, founded in 2014 and based in Berlin, Germany, is making significant strides in addressing the challenges posed by age-related diseases, such as Alzheimer's and Parkinson's, as well as emerging threats like SARS-CoV-2.

Products and Services

  • Artificial Intelligence Assisted Drug Discovery Platform

    This platform utilizes AI to speed up the process of discovering small molecule drug compounds that can potentially treat multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2. By applying advanced algorithms and machine learning techniques, this platform aims to streamline the drug discovery process, making it faster and more cost-effective.

  • PharmaKG

    PharmaKG is a biomedical knowledge graph that integrates various sources of data to facilitate a deeper understanding of the connections between genes, diseases, drugs, and biological pathways. This comprehensive database aids researchers in uncovering new insights and improving the accuracy of biomedical research outcomes.

  • Disease Diagnosis and Risk Assessment Platform

    This platform leverages AI to provide enhanced diagnostic tools and risk assessment models for healthcare providers. By analyzing vast amounts of health data, it offers more accurate diagnoses and forecasts, contributing to more personalized and effective treatment plans for patients.

Contact Information

Address: Unter den Linden 10
Phone: 49 30 700 140 449